Back to search

University of Crete (UOC)

Identification of novel molecules implicated in the pathogenesis and monitoring of lupus nephritis using microarrays: a clinical and laboratory study

Abstract

dc:description

Systemic lupus erythematosus (SLE) is a challenging autoimmune disease with manifestationsderived from the involvement of multiple organs including the kidneys, the joints, the nervoussystem as well as hematopoietic organs. Lupus nephritis (LN) is one of the most severemanifestations of SLE and a major risk factor for morbidity and mortality. The frequency isparticularly high in juvenile-onset SLE and in patients of African ancestry. Ten percent ofpatients with LN will develop end stage renal disease (ESRD). The main pathological featurein LN is immune complex formation and deposition in the kidney, which results inintraglomerular inflammation with recruitment of leucocytes and activation and proliferationof resident renal cells. Gene expression studies in LN have revealed gene networks that involve not only immune cell infiltration but also extracellular matrix formation and renal tissue repair and fibrosis.Micro-RNAs (miRNAs) come from a large family of small non-coding RNA sequences, whichare about 22 nucleotides in length. They constitute critical posttranscriptional regulators ofgene expression and act either as translational inhibitors of gene expression or by degradingmRNA transcripts since they bind to complementary sequences in the 3’ untranslated region(3’UTR) of target mRNAs. Multiple studies have shown that a cluster of key miRs are highlyexpressed in the kidney and play a critical role in renal development and function. They alsoaffect the diabetic or polycystic kidney, the kidney with IgA, acute injury or renal cellcarcinoma.The role of miRNAs as transcriptional modulators in the pathogenesis of SLE has recentlyemerged and their regulatory effects on DNA methylation pathway, type I IFN pathway,estrogen and regulatory T-cells are becoming clear. MiRNA expression has been studied inperipheral blood mononuclear cells (PBMCs), CD4 T cells, kidney biopsy tissue and EpsteinBarr virus transformed B-cell lines from patients with SLE.In this study, we investigated the role of miRNAs in human LN. To this end, we analysed themiRNA profile in kidney biopsy samples of patients with LN by TaqMan based array aimingto identify novel genes involved in disease pathogenesis. We identified important miRNAgene pairs and constructed gene networks that are potentially involved in LN pathogenesis.We focused on miR-422a, which is the most upregulated miRNA that correlates with active5histological lesions and its target Kallikrein-4 (KLK-4), a serine esterase with putativerenoprotective properties.Compared to normal tissue a 24-miRNA signature defines human LN with 9 miRNAs upregulated and 15 miRNAs down-regulated, and miR-422a exhibits the highest up-regulation(17.2-fold). These mi-RNAs with altered expression are predicted to target genes involved ininflammatory signaling pathways, membrane transporters and cell homeostasis such as TGF-β, protein kinase A, ERK/MAPK, NF-κB, HNF4A, Wnt/β-catenin signaling. Bioinformaticanalysis predicted that miR-422a has a binding site in the 3’UTR of KLK4 gene, a member ofthe kallikrein family of serine proteases. This was validated by overexpression of miR-422a,which suppressed by 65% KLK4 luciferase activity and by 82% KLK4 mRNA levels inHuman embryonic kidney - 293 cells (HEK-293).In order to monitor miR-422a/KLK4 expression during LN progression, we used NZB/W F1lupus mice. We found that at early stages miR-422a was 4.1-fold up-regulated, while KLK4mRNA levels were 3.4-fold down-regulated while at later stages miR-422a was 9.4-fold upregulated and KLK4 mRNA levels were 7.6-fold down-regulated. In unaffected NZW kidneyand human control specimens, KLK4 protein was strongly expressed, mainly in the cytoplasmof renal tubular as well as mesangial cells. In contrast, KLK4 showed absent or faint ormoderate expression in renal parenchymal cells of proteinuric NZB/W F1 and most patientswith active LN. Together, these data implicate miRNAs and KLK4, a secreted serine esterasewith angiogenic and extracellular matrix remodeling properties, in the pathogenesis ofimmune-mediated LN.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Krasoudaki, Eleni
  • Κρασουδάκη, Ελένη

Subjects

dc:subject × 9

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43809

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Krasoudaki, Eleni; Κρασουδάκη, Ελένη. Identification of novel molecules implicated in the pathogenesis and monitoring of lupus nephritis using microarrays: a clinical and laboratory study. University of Crete (UOC), 2018. http://hdl.handle.net/10442/hedi/43809